AI often makes interesting sequences, what if you didn’t need to filter these sequences based on what could be manufactured and just make everything your AI engine throws at you?

Gene therapies hold transformative potential for treating genetic diseases, cancers, and infections. However, critical bottlenecks in synthesizing viral DNA constructs—specifically inverted terminal repeats (ITRs) and promoter sequences—delay research and manufacturing. This poster explores how enzymatic DNA synthesis by Ansa Bio overcomes these challenges, enabling faster, more reliable development of viral gene therapies.